Long-acting injectable CAB/RPV_SUPLA W24

Data from the SUPLA trial up to Week 24 (with extended follow-up data available for a subset of participants) This dataset includes: Study group assignment of participants (gric) Longitudinal CD4 cell counts (cd4) and HIV-1 RNA levels (vir) of trial participants Baseline resistance-associated mutations (resi) Depression (depr) and HIV self-stigma (stig) scores HIV diagnosis date, most recent HIV-1 RNA level, and CD4 count collected during eligibility screening (diag) Participant demographics, including age, sex at birth, baseline height and weight, and underlying comorbidities (dm)